FRM
Fox Run Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-13,117
| Closed | -$73K | – | 538 |
|
2019
Q1 | $73K | Sell |
13,117
-5,083
| -28% | -$28.3K | 0.04% | 430 |
|
2018
Q4 | $121K | Sell |
18,200
-7,009
| -28% | -$46.6K | 0.06% | 456 |
|
2018
Q3 | $269K | Sell |
25,209
-13,066
| -34% | -$139K | 0.12% | 385 |
|
2018
Q2 | $459K | Sell |
38,275
-6,998
| -15% | -$83.9K | 0.15% | 280 |
|
2018
Q1 | $388K | Buy |
+45,273
| New | +$388K | 0.09% | 403 |
|
2017
Q4 | – | Sell |
-30,600
| Closed | -$376K | – | 787 |
|
2017
Q3 | $376K | Buy |
+30,600
| New | +$376K | 0.11% | 404 |
|
2017
Q2 | – | Sell |
-10,300
| Closed | -$148K | – | 735 |
|
2017
Q1 | $148K | Sell |
10,300
-11,900
| -54% | -$171K | 0.06% | 516 |
|
2016
Q4 | $307K | Buy |
+22,200
| New | +$307K | 0.16% | 279 |
|
2016
Q3 | – | Sell |
-19,100
| Closed | -$274K | – | 598 |
|
2016
Q2 | $274K | Buy |
+19,100
| New | +$274K | 0.13% | 327 |
|